Particle.news
Download on the App Store

Tom Brady Reveals His New Dog Is a Clone of Lua as Colossal Biosciences Buys Viagen

Colossal says a pre-death blood sample enabled a noninvasive clone, a project Brady backed as an investor.

Overview

  • Brady disclosed that Junie is a genetic clone of his late dog Lua, created from a blood sample taken before Lua’s death in 2023.
  • Colossal Biosciences announced it has acquired Viagen Pets and Equine, the pet‑cloning company involved in the procedure.
  • Brady said he worked with Colossal’s noninvasive cloning approach and described the result as a second chance for his family.
  • Reports note Brady holds a stake in Colossal, which is positioning pet cloning alongside stated conservation aims for endangered species.
  • Coverage highlights that pet cloning services operate legally in the United States but face strict restrictions in countries such as Germany.